Skip to main content
Pelthos Therapeutics Inc. logo

Pelthos Therapeutics Inc. — Investor Relations & Filings

Ticker · PTHS ISIN · US1711261057 US Manufacturing
Filings indexed 205 across all filing types
Latest filing 2025-07-08 Director's Dealing
Country US United States of America
Listing US PTHS

About Pelthos Therapeutics Inc.

https://ir.pelthos.com/

Pelthos Therapeutics Inc. is a biopharmaceutical company focused on commercializing innovative therapeutic products for patients with unmet medical needs. Its lead product is ZELSUVMI™ (berdazimer topical gel, 10.3%), the first FDA-approved, at-home prescription treatment for molluscum contagiosum. ZELSUVMI is based on the company's proprietary nitric oxide-releasing technology platform, NITRICIL™, which is also being utilized for a pipeline of other product candidates. The company's portfolio also includes the acquired asset Xepi (ozenoxacin) Cream, 1%.

Recent filings

Filing Released Lang Actions
Director's Dealing 2025
Director's Dealing
2025-07-08 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-07-04 English
Director's Dealing 2025
Director's Dealing
2025-07-04 English
Director's Dealing 2025
Director's Dealing
2025-07-04 English
Director's Dealing 2025
Director's Dealing
2025-07-04 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated July 1, 2025, reporting a material event: the consummation of a merger transaction, a reverse stock split, PIPE financing, and related agreements. The text includes detailed descriptions of the merger agreement, securities purchase agreement, registration rights, contribution and IP assignment agreements, and royalty agreements. The document is not a full annual or quarterly report, nor is it a transcript or earnings release. It is a current report disclosing significant corporate events and financing activities. This fits the category of Capital/Financing Update (CAP), as it primarily updates on financing activities and material definitive agreements related to capital structure changes and merger transactions.
2025-07-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.